Indivior



Ebit Ändra Datum
AstraZeneca USD 4.2B 119M 2024-12
Eli Lilly USD 5.63B 3.88B 2024-12
Glaxosmithkline GBP 1.83B 1.76B 2024-12
Halozyme Therapeutics USD 182.75M 19.56M 2024-12
Indivior 9M 51M 2024-09
J&J USD 5.35B 1.14B 2024-12
Kyowa Hakko Kirin JPY 29.15B 10.86B 2024-06
Merck USD 5.22B 339M 2024-12
Novartis USD 4.86B 286M 2024-12
Pfizer USD 4.62B 2.42B 2024-12
Sanofi EUR 2.22B 2.84B 2024-12
Supernus Pharmaceuticals USD 48.3M 19.4M 2024-12



Indivior - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Mar 2025.